Hemin toxicity: A preventable source of brain damage following hemorrhagic stroke

Redox Report

Volumn 14, Issue 6, 2009, Pages 228-235

  Robinson, Stephen R ^a   Dang, Theresa N ^a   Dringen, Ralf ^a,b   Bishop, Glenda M ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Catalase; Gsh; Hcp1; Heme; Hydrogen peroxide; Iron; Nadph; Oxidative stress; Protoporphyrin; Reactive oxygen species

Indexed keywords

ALBUMIN; ANTIOXIDANT; GLUTATHIONE; HEME OXYGENASE; HEMIN; HEMOGLOBIN; HEMOPEXIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MEMBRANE LIPID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

BRAIN CELL; BRAIN DAMAGE; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; CHELATION THERAPY; ENZYME ACTIVITY; ENZYME REGULATION; HEMATOMA; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

BRAIN INJURIES; HEME OXYGENASE (DECYCLIZING); HEMIN; HEMOGLOBINS; HEMOPEXIN; HUMANS; HYDROGEN PEROXIDE; INTRACRANIAL HEMORRHAGES; NEURONS; OXIDANTS; STROKE;

EID: 73949099862     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/135100009X12525712409931     Document Type: Review

References (68)

1. World Health Organization. The World Health Report 2003 - Shaping the Future. 2003; Available from:< http://www.who.int/whr/2003/en/whr03-en. pdf> [accessed 17 November 2009].
2. Australian Institute of Health and Welfare. Australia's Health 2008. Canberra: AIHW, 2008; Cat. no. AUS 99.
3. Anderson CS, Chakera TM, Stewart-Wynne EG, Jamrozik KD. Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-1990: incidence and outcome. J Neurol Neurosurg Psychiatry 1994; 57: 936-940.
4. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet 2009; 373: 1632-1644.
5. Broderick JP, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 1992; 326: 733-736.
6. Sloan MA, Sila CA, Mahaffey KW et al. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation 1998; 98: 1376-1382.
7. Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007; 27: 894-908.
8. Tang Y, Lu A, Aronow BJ, Wagner KR, Sharp FR. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 2002; 15: 1937-1952.
9. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344: 1450-1460.
10. Dirckx JH. (ed) Stedman's ConciseMedical Dictionary for the Health Professions, 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2001.
11. Regan RF, Wang Y, Ma X, Chong A, Guo Y. Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures. J Neurochem 2001; 79: 545-555.
12. Regan RF, Chen J, Benvenisti-Zarom L. Heme oxygenase-2 gene deletion attenuates oxidative stress in neurons exposed to extracellular hemin. BMC Neurosci 2004; 5: 34.
13. Zhao X, Grotta J, Gonzales N, Aronowski J. Hematoma resolution as a therapeutic target: the role of microglia/macrophages. Stroke 2009; 40: S92-S94.
14. Del Bigio MR, Deck JH, Davidson GS. Glial swelling with eosinophilia in human post-mortem brains: a change indicative of plasma extravasation. Acta Neuropathol 2000; 100: 688-694.
15. Garcia JH, Ho KL, Caccamo DV. Intracerebral hemorrhage: pathology of selected topics. In: Kase CS, Caplan LR. (eds) Intracerebral Hemorrhage. Boston, MA: Butterworth-Heinemann, 1994; 45-72.
16. Li C, Stocker R. Heme oxygenase and iron: from bacteria to humans. Redox Rep 2009; 14: 95-101.
17. Halliwell B, Gutteridge JMC. Free Radicals in Biology andMedicine, 4th edn. New York, NY: Oxford University Press, 2007.
18. Huffman LJ, Miles PR, Shi X, Bowman L. Hemoglobin potentiates the production of reactive oxygen species by alveolar macrophages. Exp Lung Res 2000; 26: 203-217.
19. Wagener FA, Volk HD, Willis D et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003; 55: 551-571.
20. Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 1991; 11: 1700-1711.
21. Muller-Eberhard U. Hemopexin. Methods Enzymol 1988; 163: 536-565.
22. Smith A, Hunt RC. Hemopexin joins transferrin as representative members of a distinct class of receptor-mediated endocytic transport systems. Eur J Cell Biol 1990; 53: 234-245.
23. Li RC, Saleem S, Zhen G et al. Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood FlowMetab 2009; 29: 953-964.
24. Ishiguro M, Imai Y, Kohsaka S. Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Brain ResMol Brain Res 1995; 33: 37-46.
25. Taketani S, Immenschuh S, Go S et al. Hemopexin from four species inhibits the association of heme with cultured hepatoma cells or primary rat hepatocytes exhibiting a small number of species specific hemopexin receptors. Hepatology 1998; 27: 808-814.
26. Dang TN, Bishop GM, Dringen R, Robinson SR. The putative heme transporter HCP1 is expressed in cultured astrocytes and contributes to the uptake of hemin. Glia 2010; 58: 55-65.
27. Delanghe JR, LangloisMR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 2001; 312: 13-23.
28. Shayeghi M, Latunde-Dada GO, Oakhill JS et al. Identification of an intestinal heme transporter. Cell 2005; 122: 789-801.
29. Qiu A, Jansen M, Sakaris A et al. Identification of an intestinal folate transporter and themolecular basis for hereditary folatemalabsorption. Cell 2006; 127: 917-928.
30. Laftah AH, Latunde-Dada GO, Fakih S, Hider RC, Simpson RJ, McKie AT. Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1 (SLC46A1). Br J Nutr 2009; 101: 1150-1156.
31. Lara FA, Kahn SA, da Fonseca AC et al. On the fate of extracellular hemoglobin and heme in brain. J Cereb Blood Flow Metab 2009; 29: 1109-1120.
32. Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 2005; 157: 175-188.
33. Liu Y, Ortiz de Montellano PR. Reaction intermediates and single turnover rate constants for the oxidation of heme by human heme oxygenase-1. J Biol Chem 2000; 275: 5297-5307.
34. Geddes JW, Pettigrew LC, Holtz ML, Craddock SD, Maines MD. Permanent focal and transient global cerebral ischemia increase glial and neuronal expression of heme oxygenase-1, but not heme oxygenase- 2, protein in rat brain. Neurosci Lett 1996; 210: 205-208.
35. Turner CP, Bergeron M, Matz P et al. Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin. J Cereb Blood Flow Metab 1998; 18: 257-273.
36. ScapagniniG,D'Agata V, Calabrese V et al.Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 2002; 954: 51-59.
37. Syapin PJ. Regulation of haem oxygenase-1 for treatment of neuroinflammation and brain disorders. Br J Pharmacol 2008; 155: 623-640.
38. Matz P, Turner C, Weinstein PR, Massa SM, Panter SS, Sharp FR. Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res 1996; 713: 211-222. (Pubitemid 26114842)
39. Koistinaho J, Miettinen S, Keinanen R, Vartiainen N, Roivainen R, Laitinen JT. Long-term induction of haem oxygenase-1 (HSP-32) in astrocytes andmicroglia following transient focal brain ischaemia in the rat. Eur J Neurosci 1996; 8: 2265-2272.
40. Regan RF, Guo Y, Kumar N. Heme oxygenase-1 induction protects murine cortical astrocytes fromhemoglobin toxicity.Neurosci Lett 2000; 282: 1-4.
41. WagnerKR, Sharp FR, Ardizzone TD, Lu A, Clark JF.Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 2003; 23: 629-652.
42. Ewing JF,MainesMD. Histochemical localization of heme oxygenase- 2 protein and mRNA expression in rat brain. Brain Res Brain Res Protoc 1997; 1: 165-174.
43. Vincent SR,Das S,MainesMD. Brain heme oxygenase isoenzymes and nitric oxide synthase are co-localized in select neurons. Neuroscience 1994; 63: 223-231.
44. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-554.
45. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-1046.
46. Matsumoto H, Ishikawa K, Itabe H, Maruyama Y. Carbon monoxide and bilirubin fromheme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem 2006; 291: 21-28.
47. Ryter SW, Otterbein LE. Carbon monoxide in biology and medicine. Bioessays 2004; 26: 270-280.
48. Rogers B, Yakopson V, Teng ZP, Guo Y, Regan RF. Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity. Free Radic BiolMed 2003; 35: 872-881.
49. Koeppen AH, Dickson AC, Smith J. Heme oxygenase in experimental intracerebral hemorrhage: the benefit of tin-mesoporphyrin. J Neuropathol Exp Neurol 2004; 63: 587-597.
50. Liddell JR, Hoepken HH, Crack PJ, Robinson SR, Dringen R. Glutathione peroxidase 1 and glutathione are required to protectmouse astrocytes from iron-mediated hydrogen peroxide toxicity. J Neurosci Res 2006; 84: 578-586.
51. Hirrlinger J, Dringen R. The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolic trafficking. Brain Res Rev 2009; [Epub ahead of print].
52. Laird MD, Wakade C, Alleyne Jr CH, Dhandapani KM. Hemininduced necroptosis involves glutathione depletion in mouse astrocytes. Free Radic BiolMed 2008; 45: 1103-1114.
53. Chow JM,HuangGC, LinHY, Shen SC,Yang LY, ChenYC. Cytotoxic effects of metal protoporphyrins in glioblastoma cells: roles of albumin, reactive oxygen species, and heme oxygenase-1. Toxicol Lett 2008; 177: 97-107.
54. Dringen R, Bishop GM, Koeppe M, Dang TN, Robinson SR. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 2007; 32: 1884-1890.
55. Rahman B, Kussmaul L, Hamprecht B, Dringen R. Glycogen is mobilized during the disposal of peroxides by cultured astroglial cells from rat brain. Neurosci Lett 2000; 290: 169-172.
56. Chen-Roetling J, Benvenisti-Zarom L, Regan RF. Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to hememediated oxidative injury. J Neurosci Res 2005; 82: 802-810.
57. Chen-Roetling J, Regan RF. Effect of heme oxygenase-1 on the vulnerability of astrocytes and neurons to hemoglobin. Biochem Biophys Res Commun 2006; 350: 233-237.
58. Benvenisti-Zarom L, Regan RF. Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury. Neurobiol Dis 2007; 26: 688-695.
59. 2. Eur J Biochem 1989; 185: 651-658.
60. Portsmouth D, Beal EA. The peroxidase activity of deuterohemin. Eur J Biochem 1971; 19: 479-487.
61. 2. Free Radic BiolMed 1987; 3: 107-110.
62. Gutteridge JM, Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 1988; 256: 861-865.
63. Klouche K,MorenaM, Canaud B, Descomps B, Beraud JJ, Cristol JP. Mechanism of in vitro heme-induced LDL oxidation: effects of antioxidants. Eur J Clin Invest 2004; 34: 619-625.
64. Nagababu E, Rifkind JM. Heme degradation by reactive oxygen species. Antioxid Redox Signal 2004; 6: 967-978.
65. Atamna H, Ginsburg H. Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells. J Biol Chem 1995; 270: 24876-24883.
66. Zou CG, Agar NS, Jones GL. Enhancement of glutathione-dependent haemin degradation by ascorbic acid. Biochem Pharmacol 2002; 64: 565-572.
67. Okauchi M, Hua Y, Keep RF, Morgenstern LB, Xi G. Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke 2009; 40: 1858-1863.
68. Belayev L, Obenaus A, Zhao W et al. Experimental intracerebral hematoma in the rat: characterization by sequentialmagnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy. Brain Res 2007; 1157: 146-155.